Sandoz, the generic drug unit of Swiss pharma giant Novartis, plans to spend more than $175 million outfitting its European hub for antibiotics manufacturing with new technology.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,